Dr Michael O’Neill, director of research and development at Inflection Biosciences, Darren Cunningham, chief executive at Inflection and Prof Bryan Hennessy, senior clinical lecturer at RCSI and consultant medical oncologist. Photograph: Julien Behal

Irish drug development company Inflection Biosciences will present data on its fledgling breakthrough breast cancer therapy to the American Associatio(...)

Michael McKenna, chairman, and John Fox, chief executive, at the Merrion Pharma egm. Photograph: Cyril Byrne

Shareholders in Merrion Pharma have approved the sale of some IP assets to partner Novo Nordisk and the transformation of the company into an investme(...)

Prada: results out on Tuesday
For your diary

TODAY Results: Aberdeen International ; Atari. Meetings: Conroy Gold and Natural Resources agm (Clyde Court Hotel, Dublin 4). Indicators: Euro zone in(...)

Merrion Pharmaceuticals chief executive John Fox. Photograph: Eric Luke

Merrion Pharma is back on the active list. The Elan spin-off which effectively went into hibernation during the recession has re-emerged this year un(...)